Publications by authors named "Ephraim Fuchs"

Claim this Profile
I
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy.
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, Philip H Imus, Douglas B Smith, Ephraim J Fuchs

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide.
Amy E DeZern, Marianna Zahurak, Tyler Cavin, H Pierse Byrnes, Heather J Symons, Ephraim J Fuchs

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TEMPORARY REMOVAL: Personalized Desensitization for Donor-Specific Anti-HLA Antibodies in Allogeneic Blood or Marrow Transplantation.
Christian B Gocke, Marianna Zahurak, Ilias Sinanidis, Suraya A Berger, Javier Bolaños-Meade, Ephraim J Fuchs

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation.
Shannon R McCurdy, Scott R Solomon, Brian C Shaffer, Meilun He, Yung-Tsi Bolon, Ephraim J Fuchs

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance.
Helen Stark, Quan Yao Ho, Amy Cross, Alessandro Alessandrini, Alice Bertaina, Ephraim Fuchs

Transplantation· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved overall survival with checkpoint inhibition and allogeneic transplantation in relapsed Hodgkin lymphoma.
Nadeem Tabbara, Marianna Zahurak, Cole H Sterling, Iris Margalit Trutzer, Jaroslaw Jedrych, Ephraim J Fuchs

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related encephalitis after immune checkpoint inhibitor therapy.
Monica W Buckley, Aanika Balaji Warner, Julie Brahmer, Laura C Cappelli, William H Sharfman, Ephraim Fuchs

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Ephraim Fuchs

Nature· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Bone Marrow Transplantation: Evidence from BMT CTN 1101.
Scott D Ramsey, Aasthaa Bansal, Lily Li, Paul V O'Donnell, Ephraim J Fuchs

Transplant Cell Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
Amy E DeZern, Marianna Zahurak, Heather J Symons, Kenneth R Cooke, Carol Ann Huff, Ephraim J Fuchs

Blood· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.
Cole H Sterling, Michael S Hughes, Hua-Ling Tsai, Kathryn Yarkony, Ephraim J Fuchs

Transplant Cell Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.
Huisheng Ai, Nelson J Chao, David A Rizzieri, Xiaojun Huang, Thomas R Spitzer, Ephraim Fuchs

Heliyon· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, Alexander Ambinder, Tania Jain, Ephraim J Fuchs

Transplant Cell Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study.
Michael S Hughes, Cole H Sterling, Ravi Varadhan, Richard F Ambinder, Richard J Jones, Ephraim J Fuchs

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel.
Timothy J Porter, Ana Lazarevic, Jamie E Ziggas, Ephraim Fuchs, Kiryoung Kim

Br J Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012.
Claudio G Brunstein, Paul V O'Donnell, Brent Logan, Peter Dawson, Luciano Costa, Ephraim J Fuchs

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis.
Tania Jain, Hua-Ling Tsai, Amy E DeZern, Lukasz P Gondek, Hany Elmariah, Ephraim Fuchs

Transplant Cell Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience.
Alexander Ambinder, Matthew Smith, Hua-Ling Tsai, Ravi Varadhan, Amy DeZern, Ephraim Fuchs

Clin Lymphoma Myeloma Leuk· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
Ephraim J Fuchs, Shannon R McCurdy, Scott R Solomon, Tao Wang, Megan M Herr

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes.
Paul V O'Donnell, Claudio G Brunstein, Ephraim J Fuchs, Mei-Jie Zhang, Mariam Allbee-Johnson

Transplant Cell Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide.
Katherine C Rappazzo, Marianna Zahurak, Maria Bettinotti, Syed Abbas Ali, Alex J Ambinder, Ephraim Fuchs

Transplant Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent Patients.
Claudio G Brunstein, Todd E DeFor, Ephraim J Fuchs, Chatchada Karanes, Joseph P McGuirk

Transplant Cell Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System Lymphoma.
Cole H Sterling, Hua-Ling Tsai, Matthias Holdhoff, Javier Bolaños-Meade, Leo Luznik, Ephraim J Fuchs

Transplant Cell Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation.
Carolyn M Mulroney, Muhammad Bilal Abid, Asad Bashey, Roy F Chemaly, Stefan O Ciurea, Ephraim Fuchs

Br J Haematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Mahasweta Gooptu, Rizwan Romee, Andrew St Martin, Mukta Arora, Monzr Al Malki, Ephraim J Fuchs

Blood· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis